Blaz Groselj
Ljubljana, 1000, Slovenia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Long-Term Results of a Comparison Between 15 × 2.633 Gy and 20 × 2.0 Gy for Malignant Spinal Cord Compression in Patients with Longer Expected Survival Times.
Journal: Journal of clinical medicine
Published: April 30, 2026
Radiotherapy for malignant spinal cord compression - prognostic factors for better functional outcome.
Journal: Radiology and oncology
Published: February 12, 2026
Higher Dose Irradiation for Malignant Spinal Cord Compression: Long-Term Results of the RAMSES-01 Trial.
Journal: Current oncology (Toronto, Ont.)
Published: February 02, 2026
Long-Term Results of a Propensity Score Analysis Comparing 5 × 5 Gy and 10 × 3 Gy of Radiotherapy Alone for Malignant Spinal Cord Compression.
Journal: Journal of clinical medicine
Published: November 07, 2025
Radiotherapy with 5 × 5 Gy for Personalized Treatment of Malignant Epidural Compression of the Myelon: Long-Term Results of the PRE-MODE Trial.
Journal: Journal of personalized medicine
Published: November 03, 2025
Radiotherapy with 15 × 2.633 Gy vs. 20 × 2.0 Gy in Patients with Malignant Spinal Cord Compression and Favorable Survival Prognoses: A Secondary Analysis of the RAMSES-01 Trial.
Journal: Cancers
Published: September 18, 2024
Prognostic Value of Preclinical Markers after Radiotherapy of Metastatic Spinal Cord Compression-An Additional Analysis of Patients from Two Prospective Trials.
Journal: Cancers
Published: April 21, 2022
Expression of DNA-damage response and repair genes after exposure to DNA-damaging agents in isogenic head and neck cells with altered radiosensitivity.
Journal: Radiology and oncology
Published: February 25, 2022
A New and Easy-to-Use Survival Score for Patients Irradiated for Metastatic Epidural Spinal Cord Compression.
Journal: Practical radiation oncology
Published: December 26, 2021
Data on phenylalanine-to-tyrosine ratios in assessment of tetrahydrobiopterin (BH4)-responsiveness in patients with hyperphenylalaninemia.
Journal: Data in brief
Published: November 29, 2021
Last Updated: 09/26/2026